CSO Rob Roscow: Transforming Research From Mydecine’s 3 Pillars Into Repeatable Medicine Mar 23, 2021
Creso Pharma is an “Open Minded Company” Providing Investors Optionality, says Bruce Linton Mar 22, 2021